Nuclear medicine in nerphology

2,391 views

Published on

Published in: Health & Medicine, Technology

Nuclear medicine in nerphology

  1. 1. Nuclear Imaging in Nephro-urology
  2. 2. Introduction  Uses pharmaceuticals – labels with radionuclides (radiopharmaceuticals) - radiotracers  Administers these to patients – radiation emitted is detected  Formation of an image using a gamma camera or positron emission tomography  Radionuclide imaging / nuclear scintigraphy  Shows the physiological function of the system being investigated
  3. 3. Introduction  Radiotracers – DTPA, MAG3, OIH etc – taken up by kidneys, then excreted into urinary tract  Serial frames of posterior view – acquired 20-30 min immediately after tracer injection  Frame rate –  1-3s per frame for one min to assess perfusion (perfusion phase)  10-15s per frame for 4 min to assess function (function phase)  10-30s per frame to assess urinary system (excretion phase)
  4. 4. Overview of renal radiopharmaceuticals Renal handling Radiopharmaceu tical Imaging Clinical use Glomerular filtration 51 Cr-EDTA No GFR 99mTc-DTPA Yes GFR Tubular secretion 123I/131I-OIH Yes ERPF 99mTc-MAG3 Yes ERPF 99mTc-EC Yes ERPF Tubular retention 99mTc-DMSA Yes Cortical imaging 99mTc-GH Yes Cortical imaging
  5. 5. Glomerular filtration  Gold standard – inulin clearance  Radionuclide of choice – 51Cr-EDTA – clearance closest to that of inulin  99mTc-DTPA – technetium-99m-diethylenetriamine pentaacetic acid – correlates well with 51Cr-EDTA and inulin • Taken up by glomerular filtration, not secreted/reabsorbed by tubules  99mTc-DTPA can be used for gamma camera imaging  Least expensive renal radiopharmaceutical  Low radiation dose  Small fraction may be bound to protein – not a problem for routine measurement of GFR  Once reaches kidney – 20% is accumulated and remainder flows away, i.e. extraction fraction of DTPA is 20%
  6. 6. Tubular secretion (1)  p-Aminohippuric acid (PAH) – gold standard for measurement of tubular cell function and its clearance – effective renal plasma flow (ERPF)  123I-OIH and 131I-OIH – cleared by tubular secretion (small fraction by glomerular filtration)  Clearance rate – approx 500-600ml/min  Extraction of 131I-OIH depends on renal plasma flow and extraction from plasma (proximal tubules)  123I-OIH – better imaging qualities, more expensive
  7. 7. Tubular secretion (2)  99mTc-MAG3  highly protein-bound, cleared mainly by proximal tubules  High extraction fraction (50%) – better scintigraphic images  99mTc-I, I and d,d-ethylenedicysteine (EC) – better than 99mTc-MAG3
  8. 8. 65 year-old with contrast nephropathy on CKD – better image of TC-MAG than DTPA scan
  9. 9. Tubular retention  99mTc-dimercaptosuccinic acid (DMSA)  Excellent cortical imaging agent  Concentrates largely in renal cortex (lesser in liver)  Strongly bound to proteins  At 2h post-injection : 50% retained in kidneys, no visualization of urinary collecting system  99mTc-glucoheptonate (GH)  Filtered by glomerulus and bound by tubules  Highly protein-bound – glomerular filtration partial
  10. 10. DMSA  IV injection – bound to proximal tubules  Indications:  Assessment of kidneys in acute phase of UTI (acute pyelonephritis)  Assessment of kidneys in late phase of UTI – detection of scar  Assessment of horseshoe, solitary or ectopic kidney  Localisation of poor or very poorly functioning kidney  Assessment of renal function in the presence of an abdominal mass BNMS guidelines
  11. 11. DMSA  Pitfalls  Acute and chronic pyelonephritis cannot be distinguished on the cortical scan. If a defect is present 6 months after the last UTI then this is a scar  A recent UTI may cause temporary reduced uptake / focal defect and a follow-up DMSA scan should be undertaken  The diagnosis of renal scars is difficult in the infant under 3-6 months of age because of renal immaturity. If appropriate the scan should be delayed  Controversies  To obtain the highest resolution, some centres recommend the use of a pin hole collimator, however many institutions obtain high resolution images with clear definition between cortex and medulla without the use of pin-hole collimation  Currently there is no evidence to support the routine use of SPECT in children to delineate focal defects BNMS guidelines
  12. 12. Analytic methods  Various methods  Single-sample methods and camera-based methods suitable for busy clinical practice  Single-sample – single venous blood sampling after tracer injection, and plasma radioactivity is measured  Plasma activity and injection dose substituted in a predefined, empiric equation = renal clearance
  13. 13. Analytic methods  Camera-based methods – renal uptake early after tracer injection reflects renal function  Calculate renal function from imaging data without blood sampling  A region of interest (ROI) is drawn for each kidney to estimate activity, then do a background subtraction, then attenuation correction for depth of each kidney, then normalized to the injection dose – finally substituted to an empiric equation = renal clearance  Less accurate than single-sample method  Can assess right and left kidney function separately – split renal function  Can do combined single-sample and camera-based methods Isotopic Scan for Diagnosis of Renal Disease. Yusuke Inoue et al. Saudi Journal of Kidney Diseases and Transplantation. 15(3) 2004; 257-64
  14. 14. Analytic methods  Renogram curves – overview of the time course of renal radioactivity  Generated by setting an ROI for each kidney  Radioactivity in a kidney derives from renal parenchyma, upper tract and overlapping extrarenal tissues  Do background subtraction - renal parenchyma and upper tract  In normal subjects – a renogram demonstrates rapid increase during perfusion and function phases, then rapid decline during excretion phases  Hypofunction flattens the slopes during the function and excretion phases  Obstruction causes delayed excretion  Cannot discriminate between retention in renal parenchyma and that in urinary tract – visual assessment of scintigraphy images needed…
  15. 15. Clinical uses:  Renal clearance measurements  Obstruction  Infection  Renal artery stenosis  Renal transplant
  16. 16. Renal clearance measurements  GFR and estimation of split renal function  Renal Plasma Flow
  17. 17. Glomerular Filtration Rate  Substances suitable for measuring GFR  Low protein binding  Negligible non-renal excretion  Freely filtered  Chemically stable and inert  INULIN – Gold standard
  18. 18. GFR  Radioactive tracers – simplifies sample measurements  Single injection  51Chromium ethylenediamine tetraacetic acid (51Cr-EDTA) – agent of choice  99mTc-DTPA – can be used – prepared from kits - variability in stability and protein-binding  Short half-life (6 hours)  Advantage – imaging and GFR measurement can be performed at the same time
  19. 19. GFR - 51Cr-EDTA  After iv injection – EDTA rapidly diffuses throughout bloodstream, equilibrates more slowly with EVF  Measure the plasma conc at 2, 3 and 4 hours after injection  Back extrapolation to time of injectiondistribution volume of extacellular space, and slope of declining conc is fractional clearance of this space  GFR  Expressed in ml/min or normalised to body surface area
  20. 20. GFR - 51Cr-EDTA  A number of attempts to simplify GFR measurements  Considerable variation due to age and body dimensions  High errors  All single injection methods – assume patient in a steady state with respect to hemodynamics and fluid exchange  Not accurate e.g. major surgery, transfusion or dialysis
  21. 21. EDTA  GFR - plasma clearance curve - which required multiple blood samples to be taken over a period of several hours  Slope-intercept method – after numerous simplification  number of sample : 1 (recommended by the Radionuclides in Nephrology Committee on Renal Clearance (Blaufox et al, 1996) )  It is recommended that the plasma clearance of EDTA from venous samples be taken as the standard measure of GFR  DTPA does have some technical advantages over EDTA but normal ranges are not so well established  Small systematic differences have been observed between GFR measurements obtained from EDTA and DTPA (Rehling et al, 1984, Fleming et al, 1991, Biggi et al, 1995)
  22. 22. Renal plasma flow  Tracers that are filtered and actively secreted by renal tubules – extracted with  efficiency from plasma perfusing kidneys  Ortho-idohippurate (OIH) – 90% removed by kidneys on a single pass  ERPF  Less widely available  99mTc-labelled compounds – 99mTc-MAG3:  Higher protein binding and lower extraction efficiency  Tubular extraction rate  Need multiple blood samples for accuracy
  23. 23. Clinical uses: • Renal clearance measurements • Obstruction • Infection • Renal artery stenosis • Renal transplant
  24. 24. Obstructive Uropathy  Obstruction of the urinary flow anywhere from the renal pelvis to the urethra  Can be acute or chronic  In adults most commonly caused by tumor or prostatic enlargement (hyperplasia or malignancy)  Need to have bilateral obstruction in order to have renal insufficiency
  25. 25. Prenatal Hydronephrosis  Prenatal hydronephrosis (collecting system dilatation) can be identified on prenatal ultrasound in about 1% of patients (0.3-4.5% and is bilateral in 37-57% of cases.  Followup is generally recommended if the AP diameter of the collecting system is 7-10 mm during the 3rd trimester of pregnancy.
  26. 26. Prenatal Hydronephrosis  The first follow up exam should be performed during the 1st week after birth- but not during the first 72 hours because of reduced urine output after delivery.  On post-natal follow-up, the dilatation will resolve in 20-50% of cases.
  27. 27. Obstruction/Urinary tract dilatation  Diuretic renography – diagnostic work-up of upper tract dilatation, and follow-up of patients with hydronephrosis  Method of choice – to differentiate a dilated unobstructed urinary system from a true stenosis  Can also assess urine flow and renal function
  28. 28. In children:  Sedation should be avoided – may interfere with bladder voiding  Increased radiation exposure to bladder mucosa – concern  Receiving the child with parents in a dedicated, calm environment  If needed – local guidelines for sedation  Short inhalation of equimolar mixture of nitrous oxide and oxygen J Nucl Med 2006; 47:1819–1836
  29. 29. Diuretic renography  99mTc-mercaptoacetyltriglycine(MAG3) and 123I-orthoiodohippurate (OIH) are preferred  higher renal extraction ratio and rapid plasma clearance, especially in infants and young children and in patients with impaired renal function  Use of frusemide 1mg/kg (max 20mg in children, 40mg adults  Recommended by Society of Nuclear Medicine  European Nuclear Medicine Association
  30. 30. Diuretic renography  Timing of frusemide administration  20 min or more after tracer injection – max distension of renal pelvis or ureter can be visually assessed (F+20)  15 min before tracer injection – diuretic response of kidney is maximal (F-20)  Diuretic response is evaluated by visual and quantitative interpretation of the dynamic acquisition  Postmicturition images are mandatory because a full bladder may delay urinary flow even in an unobstructed system
  31. 31. Diuretic renography  The role of bladder catheterization – debated - not recommended in clinical routine practice  Older children and adults - renography is performed after bladder emptying  Non–toilet-trained children, spontaneous micturition is usually observed during the acquisition  Adequate functioning of the affected kidney (GFR > 15 mL/min) and adequate hydration are major determinants of the response to frusemide
  32. 32. Limitation/pitfall of diuretic renography
  33. 33. 6/12 old boy, febrile UTI by age of 2/12, normal ultrasound and VCUG
  34. 34. 9 year-old boy – febrile UTI
  35. 35. Indirect radionuclide cystography
  36. 36. 4 year-old girl treated conservatively for left PUJ stenosis detected prenatally Left kidney 20min after injection After miction 50 min after injection
  37. 37. Clinical uses: • Renal clearance measurements • Obstruction • Infection • Renal artery stenosis • Renal transplant
  38. 38. UTI  Frequent in children  Affect girls 2x > boys  80% first infections diagnosed during first 2 years of life  5% in infants and young children – fever of unexplained origin  Diagnosis – urine culture  Risk of renal damage – delay of diagnosis/treatment, number of UTIs
  39. 39. UTI  The Subcommittee on Urinary Tract Infection of the American Academy of Pediatric Committee on Quality Improvement recommended imaging (mainly sonography, VCUG, or radionuclide cystography) of the urinary tract in children younger than 2 y old but considered the role of cortical renal scintigraphy still to be unclear despite its recognized high sensitivity
  40. 40. Cortical scintigraphy  Scintigraphy with 99mTc-dimercaptosuccinic acid (DMSA) – simple and non-invasive  Static imaging 2-4 hours after iv injection  Delayed or post-frusemide images in hydronephrosis  The sensitivity of 99mTc-DMSA for the detection of parenchymal defects due to infection - from 80% to 100%  does not allow differentiation of acute pyelonephritis from renal scars
  41. 41. Cortical scintigraphy  Abnormal findings on cortical scintigraphy are found in 52%–78% of children during acute pyelonephritis, and the risk that a renal scar will develop can reach 60%  The role of cortical scintigraphy is still largely debated in acute pyelonephritis but is widely accepted in the detection of renal scars  99mTc-DMSA scintigraphy is the reference method for detecting renal sequelae after UTI, is more sensitive than sonography, and should be performed no sooner than 6 mo after the last documented UTI  Also used to detect scars in VUR
  42. 42. Radionuclide cystography  Direct radionuclide cystograhy  A radiologic-VCUG alternative - lower radiation burden  As invasive as VCUG – bladder catheterization  More sensitive – acquisition is continuous in both filling and voiding phase  Indirect radionuclide cystography  Performed after conventional renography with 99mTc- MAG3 or 123I-OIH – high excretion rate  No need catheterization  Less sensitive and specific than VCUG/direct cystography
  43. 43. Clinical uses: • Renal clearance measurements • Obstruction • Infection • Renal artery stenosis • Renal transplant
  44. 44. Renovascular hypertension  3 – 5% of all hypertensive patients  15 – 30% of referred patients for refractory hypertension  Renal hypoperfusion  secondary activation of renin-angiotension system  Stenotic or obstructive lesion within renal artery  Potential curable cause of hypertension  70-90% - atherosclerosis  10-30% - fibromuscular dysplasia
  45. 45. Renovascular hypertension  RVH is a consequence of activation of RAS with concomitant release of angiotensin II (a vasoconstrictor) and aldosterone (leading to plasma volume expansion) to maintain physiologic renal perfusion by increasing blood pressure  Clinical features:  abdominal bruits, rapid onset of hypertension, refractory hypertension, unilateral renal atrophy, azotemia (esp when worsened by ACEi or ARB), unexplained azotemia/hypokemia  Episodes of flash pulmonary edema in patients with relatively well-preserved systolic function  Gold standard – Renal angiography
  46. 46. Captopril-enhanced renography  To determine which patients can expect normalization of BP or improvement of BP control after revascularization  ACEi reduce the conversion of angiotensin I  angiotensin II - diminishing the vasoconstriction of the postglomerular efferent arteriole and decreasing the GFR, which can be detected by scintigraphy  Both glomerulus-filtered (99mTc-DTPA) and tubule- secreted (99mTc-MAG3 or 123I-OIH) - currently used  ACEi – captopril (25-50mg) orally 60min before renography; or iv enalaprilat (40mg/kg) over 325min >15min before renography
  47. 47. Captopril-enhanced renography  Known pitfalls  erroneous results are  food ingestion within 4 h before receiving captopril,  dehydration, hypotension,  or a full bladder impairing drainage  ACEi enhanced renography now is rarely used as the primary imaging tool  Most reliable in predicting recovery in patients with FMD
  48. 48. 35 year-old : Doppler ultrasound showing parvus-tardus pattern with collapsed resistance index Normal right kidney
  49. 49. Left kidney Right kidney
  50. 50. 75 year-old lady – OIH study
  51. 51. Typical diagnostic workup for RVH Doppler sonography, CT angiography or MRA ACE inhibitor renography Renal angiography and treatment
  52. 52. Clinical uses: • Renal clearance measurements • Obstruction • Infection • Renal artery stenosis • Renal transplant
  53. 53. Renal transplantation  Comprehensive evaluation of renal transplants – in differential diagnosis of medical and surgical complications in early post-op and in long-term follow up  Selection of patients for biopsy and for various drug regimens  Anuric ATN – improving indices of renal function (ERPF, uptake of tubular tracers) – indicates resolution of tubular injury  The protocol: a flow study, scintigram of kidneys, prevoid and postvoid bladder image, injection site image, time/acitivity curves of graft and bladder, and quantitative data of perfusion, function and tracer transit Report of the Radionuclides in Nehrourology Committee for evaluationof transplanted kidney (review of techniques). Dubovsky et al. Semin Nucl Med. 1999 Apr;29(2):175-88
  54. 54. Renal transplantation  Flow study – 99mmercaptoacetyltriglycine or DTPA  Quantitative analysis and function phase should include images and time/activity curves  Serial studies: decline in function and poor perfusion indicative of acute rejection  A normally appearing scintigram without cortical retention, low function – chronic rejection  Diuretic renogram - to exclude obstruction Report of the Radionuclides in Nehrourology Committee for evaluationof transplanted kidney (review of techniques). Dubovsky et al. Semin Nucl Med. 1999 Apr;29(2):175-88
  55. 55. Renal transplantation  A baseline study should be performed within 1 – 2 days of operation – to allow comparison of serial studies because of deteriorating renal function  DTPA – tracer of choice in early stages  DTPA/MAG3 can be used later stages
  56. 56. Indications for renography in transplantation
  57. 57. Renography in transplantation  Ultrasound – 1st line evaluation in renal graft dysfunction  Renography – must be available on emergency basis  Non-visualization – irremediable loss of function  May not differentiate rejection from ischemia (RAS)  ACEi renography – help determine whether arterial hypertension is dependent on RAS  Help in diagnosis of urinary complications – obstruction or leak
  58. 58. Graft dysfunction 1d post- transplantation in a 41 y-old woman
  59. 59. 5d post-transplantation
  60. 60. 6d post-transplantation – sudden anuria and abdominal pain
  61. 61. Decreased graft function 5/12 post-transplant, renogram showed an OIH accumulation within normal limits, normal peak, but delayed elimination 1-min images reveal tracer retention in parenchyma without outflow impairment – suggesting potential CNI toxicity
  62. 62. Conclusion  Role of nuclear medicine – in investigation of renal parenchymal function and upper urinary tract abnormalities  Radiation burden low  Do not require sedation or specific patient preparation  Easy to perform  Knowledge of renal patho-physiology and recognition of limitation and technical pitfalls essential

×